| style="padding:10px;" | Non-attorney patient advocate
...mily and caregiver support. She is a regular author on the firm-affiliated patient-resource publications mesothelioma.net and mesothelioma-lung-cancer.org.
...
4 KB (492 words) - 22:04, 29 May 2026
| style="padding:10px; border-bottom:1px solid #dee2e6;" | Director of Patient Support
| style="padding:10px;" | Non-attorney patient advocate
...
5 KB (569 words) - 22:04, 29 May 2026
...e="padding:10px; border-bottom:1px solid #dee2e6;" | Executive Director of Patient Support & Medical Assistance
| style="padding:10px;" | Non-attorney patient advocate
...
5 KB (659 words) - 22:04, 29 May 2026
| style="padding:10px;" | Non-attorney patient advocate
....net and mesothelioma-lung-cancer.org, both Danziger & De Llano–affiliated patient-resource publications.
...
6 KB (743 words) - 22:04, 29 May 2026
...15.6 months to 19.6 months.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer I
| style="padding:10px; font-weight:bold;" | Veteran Patient Population
...
22 KB (2,918 words) - 23:25, 14 May 2026
...specifically for [[Asbestos Exposure|asbestos exposure]] victims and their advocates.
* [https://mesothelioma.net/ Mesothelioma.net] — Comprehensive patient and family resources
...
25 KB (2,946 words) - 12:40, 21 May 2026
|author=David Foster, Patient Advocate, Danziger & De Llano
...r-bottom:1px solid #dee2e6;" | 14–19 months (all comers); 18 months in 529-patient series (Sugarbaker 2014)<ref name="sugarbaker_14" />
...
49 KB (6,529 words) - 23:25, 14 May 2026
...helioma patients worldwide.<ref>[https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq Mesothelioma Treatment (PDQ)], National Cancer I
* '''Advocates for patients in countries still using asbestos''' — Through his IASLC role,
...
28 KB (3,537 words) - 23:25, 14 May 2026
...ant pleural mesothelioma including MARS 2 trial results, HITHOC protocols, patient selection criteria, complication rates, recovery timeline, and high-volume
|author=David Foster, Patient Advocate, Danziger & De Llano
...
46 KB (6,121 words) - 05:05, 25 May 2026
...gimens achieve 50% local response vs 39% for lower-dose fractions in a 189-patient Dutch series<ref name="controversies" />
...IT trial and 3 prior studies found no benefit, overturning the original 40-patient Boutin result<ref name="pit-manchester" /><ref name="controversies" />
...
44 KB (5,659 words) - 23:26, 14 May 2026
* '''Patient navigation triples minority clinical trial enrollment''' — from 13% to 41%
...000–2019):''' White 1.1 per 100,000; Black 0.5 per 100,000 (p=0.01); total patient population 91.3% White, with declining trends across all racial groups<ref
...
43 KB (5,234 words) - 23:25, 14 May 2026
...Act (LHWCA).<ref name="dandell-advocates">[https://dandell.com/advocates/ Advocates | Danziger & De Llano LLP]</ref>
...egal rights.<ref name="dandell-advocates2">[https://dandell.com/advocates/ Advocates | Danziger & De Llano LLP]</ref>
...
42 KB (5,223 words) - 23:25, 14 May 2026
...SO trial found palliative care particularly benefited caregivers even when patient outcomes did not change<ref name="sdcarers" /><ref name="pmcneeds" />
* '''Caregiver mental health vs. patient mental health''' — caregivers of mesothelioma patients often score worse on
...
71 KB (9,125 words) - 05:05, 25 May 2026
...'60+ bankruptcy trust administrators'''. According to [https://dandell.com/advocates/ Danziger & De Llano's attorney team], the institutional knowledge required
...anagement," explains David Foster, Client Advocate at [https://dandell.com/advocates/ Danziger & De Llano].
...
30 KB (3,666 words) - 23:25, 14 May 2026
...ab combination, CheckMate 743 trial results, emerging clinical trials, and patient access programs.
|author=David Foster, Patient Advocate, Danziger & De Llano
...
61 KB (7,899 words) - 23:55, 29 May 2026
...x solid #dee2e6;" | Median OS 8 months regardless of platinum agent in 787-patient Flatiron Health cohort (2011–2019)<ref name="carbo-realworld" />
...CRS-HIPEC vs ~12 months systemic chemo alone; 5-year survival 38–74% (804-patient systematic review)<ref name="hipec-review" />
...
48 KB (5,868 words) - 23:25, 14 May 2026
* '''Younger patient distribution than pleural disease''' — approximately 25% of MMTVT patients
...ent (2%), beta-HCG in 2 (4%), and LDH in 3 (6%). Normal tumor markers in a patient with a testicular or paratesticular mass should broaden the differential di
...
50 KB (6,428 words) - 23:26, 14 May 2026
|author=David Foster, Patient Advocate, Danziger & De Llano
...nts, treatment selection depends on lung expandability, expected survival, patient preference, and whether simultaneous diagnostic biopsies are needed.<ref na
...
64 KB (8,584 words) - 23:26, 14 May 2026
...or worker safety—a combination that made him both revered by public health advocates and despised by asbestos industry executives.
...//mesotheliomalawyersnearme.com/ Mesothelioma Lawyers Near Me], or explore patient resources and support at [https://mesothelioma.net/ Mesothelioma.net].
...
26 KB (3,494 words) - 23:25, 14 May 2026
..."arban_act" /> The act is named in honor of Alan Reinstein, a mesothelioma patient and longtime asbestos ban advocate.
...
25 KB (3,346 words) - 14:15, 25 April 2026
